Abstract:Nucleic acid delivery by viral and non-viral methods has been a cornerstone for the contemporary gene therapy aimed at correcting the defective genes, replacing of the missing genes, or downregulating the expression of anomalous genes is highly desirable for the management of various diseases. Ostensibly, it becomes paramount for the delivery vectors to intersect the biological barriers for accessing their destined site within the cellular environment. However, the lipophilic nature of biological membranes and their potential to limit the entry of large sized, charged, hydrophilic molecules thus presenting a sizeable challenge for the cellular integration of negatively charged nucleic acids. Furthermore, the susceptibility of nucleic acids towards the degrading enzymes (nucleases) in the lysosomes present in cytoplasm is another matter of concern for their cellular and nuclear delivery. Hence, there is a pressing need for the identification and development of cationic delivery systems which encapsulate the cargo nucleic acids where the charge facilitates their cellular entry by evading the membrane barriers, and the encapsulation shields them from the enzymatic attack in cytoplasm. Cycloamylose bearing a closed loop conformation presents a robust candidature in this regard owing to its remarkable encapsulating tendency towards nucleic acids including siRNA, CpG DNA, and siRNA. The presence of numerous hydroxyl groups on the cycloamylose periphery provides sites for its chemical modification for the introduction of cationic groups, including spermine, (3-Chloro-2 hydroxypropyl) trimethylammonium chloride (Q188), and diethyl aminoethane (DEAE). The resulting cationic cycloamylose possesses a remarkable transfection efficiency and provides stability to cargo oligonucleotides against endonucleases, in addition to modulating the undesirable side effects such as unwanted immune stimulation. Cycloamylose is known to interact with the cell membranes where they release certain membrane components such as phospholipids and cholesterol thereby resulting in membrane destabilization and permeabilization. Furthermore, cycloamylose derivatives also serve as formulation excipients for improving the efficiency of other gene delivery systems. This review delves into the various vector and non-vector-based gene delivery systems, their advantages, and limitations, eventually leading to the identification of cycloamylose as an ideal candidate for nucleic acid delivery. The synthesis of cationic cycloamylose is briefly discussed in each section followed by its application for specific delivery/transfection of a particular nucleic acid.

How Are Nucleic Acids Released in Cells from Cationic Lipid-Nucleic Acid Complexes?

Mechanism of DNA Release from Cationic Liposome/dna Complexes Used in Cell Transfection.

Cationic lipids, phosphatidylethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (review).

Complex Size and Surface Charge Determine Nucleic Acid Transfer by Fusogenic Liposomes

Mechanism of Cationic Lipid Induced DNA Condensation: Lipid-DNA Coordination and Divalent Cation Charge Fluctuations

Cell Membranes Open "doors" for Cationic Nanoparticles/Biomolecules: Insights into Uptake Kinetics

Transitions between Distinct Compaction Regimes in Complexes of Multivalent Cationic Lipids and DNA

DNA transfection mediated by cationic liposomes containing lipopolylysine: characterization and mechanism of action

Cytoplasmic Reactive Cationic Amphiphiles for Efficient Intracellular Delivery and Self-Reporting Smart Release

Nuclear Lipid Droplets Exit to the Cytoplasm: A Novel Mechanism of Non-Nuclear Pore-Dependent Material Exchange

DNA Nanostructure-Programmed Like-Charge Attraction at the Cell-Membrane Interface

Cationic Glyconanoparticles: Their Complexation with Dna, Cellular Uptake, and Transfection Efficiencies

Release of Cationic Polymer-Dna Complexes from the Endosome: A Theoretical Investigation of the Proton Sponge Hypothesis.

Competitive binding and molecular crowding regulate the cytoplasmic interactome of non-viral polymeric gene delivery vectors

Noncationic Material Design for Nucleic Acid Delivery

DNA release dynamics from reducible polyplexes by atomic force microscopy.

Cationic cycloamylose based nucleic acid nanocarriers

Cationic lipid nanosystems as carriers for nucleic acids

The engineering challenges and opportunities when designing potent ionizable materials for the delivery of ribonucleic acids

Controlled Release of Hydrophilic Guest Molecules from Photoresponsive Nucleolipid Vesicles

Mechanism for the Endocytosis of Spherical Nucleic Acid Nanoparticle Conjugates*